Current Issue Search Articles Instructions for authors

 HOME | Login   


 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
 Users online: 813

  In this article
    Case Report
    Article Figures

 Article Access Statistics
    PDF Downloaded461    
    Comments [Add]    

Recommend this journal

Year : 2009  |  Volume : 3  |  Issue : 1  |  Page : 16-20    Table of Contents


Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy

1 Adana Numune Egitim ve Arastirma Hastanesi, Department of Orthopedics, Adana, Turkey
2 Adana Numune Egitim ve Arastirma Hastanesi, Department of Dermatology, Adana, Turkey
3 Department of Radiology, Mustafa Kemal University, Faculty of Medicine, Antakya, Turkey
4 Adana Numune Egitim ve Arastirma Hastanesi, Department of General Surgery, Adana, Turkey
5 Adana Numune Egitim ve Arastirma Hastanesi, Department of Pathology, Adana, Turkey

Correspondence Address:
Ertugrul Egilmez
Department of Radiology, Mustafa Kemal University, Faculty of Medicine, 31100 Antakya
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/0973-6042.48432

Rights and Permissions


Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Article in PDF (527 KB)
Reader Comments
Access Statistics
Citation Manager
Add to My List *
* Registration required (free)


We report a case of this rare tumor and describe the surgical approach that we adopted and the clinical outcome; we also report his condition at 24 months' follow-up. Although treatment was with radical surgery, sufficient shoulder function could be obtained in our patient. We also describe the interesting MR findings of this tumor which correlated well with the histopathologic findings.

Keywords: Dermatofibrosarcoma protuberans, soft tissue tumor, surgical therapy

How to cite this article:
Yilmaz A, Cenesizoglu E, Egilmez E, Onel S, Mustu M, Cennet A. Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy. Int J Shoulder Surg 2009;3:16-20

How to cite this URL:
Yilmaz A, Cenesizoglu E, Egilmez E, Onel S, Mustu M, Cennet A. Dermatofibrosarcoma protuberans: A case report of a rare, bulky tumor that was managed with surgical therapy. Int J Shoulder Surg [serial online] 2009 [cited 2019 Aug 21];3:16-20. Available from:

   Introduction Top

Dermatofibrosarcoma protuberans (DFSP) is a relatively rare, slow-growing, malignant mesenchymal tumor of the dermis. The tumor accounts for less than 0.01% of all malignancies. [1] The yearly incidence rate between 1982 and 2002, as per the population-based cancer registry in France, was reported as three cases per million population. [2] The neoplasm is locally invasive and relapses, due to insufficient excisions, are not rare. Remote metastases are also rare, but when it does occur the common sites are the lungs and the regional lymph nodes. [3],[4]

DFSP usually begins as a polypoid protuberance or an indurated plaque on the skin. With time the tumor grows in size and ulcerations may appear on nodular projections on its surface. The tumor is mostly located on the trunk, with the other common locations being the head and neck. The size of the tumor is generally under 5 cm. [3],[5],[6] In the present case, the bulky (13 × 18 cm) tumor was located on the proximal arm, which is unusual. MRI of the lesion revealed multiple tail- like extensions into the deep muscle planes, which was also demonstrated by histopathology. This finding is useful during surgical planning.

We report a case of this rare tumor and describe the surgical approach that we adopted and the clinical outcome; we also report his condition at 24 months' follow-up. Although treatment was with radical surgery, sufficient shoulder function could be obtained in our patient. We also describe the interesting MR findings of this tumor which correlated well with the histopathologic findings.

   Case Report Top

The patient (F.O.; 46-year-old male) was admitted to the Department of Orthopedics and Traumatology Service of Adana Numune Education and Research Hospital as 8562 protocol number on April 2006. He complained of a sizable, bulky tumor on the proximal part of his right arm, partially abutting on the shoulder; there was an ulceration present on the surface of the mass. According to the patient, he had first noticed a 1-cm nodule on his arm 5 years ago, which had grown gradually since then to attain its present size. He also explained that his dread of injections had prevented him from seeking medical aid earlier.

The physical examination revealed a huge mass on the proximal, anterolateral aspect of the right arm and shoulder; there were potato-like projections arising from the mass. The tumor was 13 × 18 cm in size; the overlying skin was of normal color, with hemorrhagic ulcerations on it [Figure 1]. The tumor was fixed to the deep tissues. Regional lymph nodes were not enlarged. Clinical examination did not reveal any other abnormality.

The scout x-rays of the shoulder and proximal arm revealed a huge bulky soft tissue mass without involvement of the bony structures. The lung fields were normal on chest x-ray. MRI was done to evaluate the communications of tumor with neighboring structures and showed a multilobulated, relatively homogenous, high-signal-intensity solid mass with focal invasions at the deltoid muscle and deep extensions into the biceps, brachialis, and triceps muscles inferiorly; there was also infiltration of the cutaneus and subcutaneous tissues on fat-suppression images [Figure 2]. The mass was 13 cm in longitudinal diameter and extended 6 cm inferiorly. The dermal extension of the tumor had multiple tail-like projections up to 15 mm long. The imaging findings were strongly suggestive of malignancy and so we decided to operate. To the best of our knowledge, the focal invasions in the deltoid muscle and tail-like projections into dermis are important and new findings in the MR imaging of this tumor [Figure 3]. The mass lesion revealed a low-signal-intensity appearance with tiny tail-like extension superiorly on T1-weighted image [Figure 4]. Nuclear study revealed no abnormality. Laboratory studies were also within normal limits.

In view of the possibility of peripheral extension of the tumor tissue, a wide resection was planned so as to include more than a 3-cm margin of normal cutaneus tissue, at least 2 cm of the underlying normal tissue of the deltoid muscle, and also approximately 0.5 cm of noninfiltrated superficial layers of the other arm muscles [Figure 5]. We also decided to do a flap revision to cover the surgical defect 2 weeks later in order to evaluate the intact peripheral tissue.

The surgical procedure was carried out as planned and the surgical defect was covered. Macroscopic examination of the excised tumor revealed potato-like bulbous extensions on its surface. The cut surfaces were pink-white in color. Microscopic examination, which included histopathologic and immunohistochemical analysis with CD-34, confirmed the diagnosis of DFSP [Figure 6]. The surgical boundaries were found to be negative after operation.

Three weeks after repair of the surgical defect, there was limitation of the range of movement of the shoulder, with only 20° abduction and minimal medial-lateral rotation. A physical therapy and rehabilitation program was prescribed, and after 3 months of an intensive exercise program, the performance of the shoulder had improved, with 90° abduction, 70° external rotation, and 25° internal rotation [Figure 7] and [Figure 8].

We followed up the patient every 3 months. The patient's general condition was very good at the last follow-up visit, 24 months after the surgery. No evidence of local relapse was seen, though there was a residual deformity at the operation site. No enlargement of cervical and axillary lymph nodes was present. Hematologic tests and radiographs of the shoulder, arm, and chest were normal. Follow-up MR examination was normal. Bone scintigraphy also showed no abnormality. At the last follow-up, the patient was actively using his arm and reported that he was carrying out his routine daily activities easily.

   Discussion Top

DFSP was first described clinically in 1890. Darrier and Ferran described the tumor as 'progressive and recurrent dermatofibrosarcoma or skin fibrosarcoma.' The term 'dermatofibrosarcoma protuberans' was first used in 1925 by Hoffman. [3],[7] The entity originates from the dermis and is a rare malignant dermal tumor. Although it can be seen at any age, it is found mostly between 30-50 years of age. Approximately 10% of patients are children. The incidence is 0.8-4.2 per million population. The tumor afflicts both sexes approximately equally.

The cause of DFSP is not known. However, cytogenetic investigations have shown tumor cells with chromosomal anomalies together with mononuclear cellular origin. Some studies also describe the occurrence of DSFP at vaccination sites, in the scars of surgical incisions or of dermal burns, and in areas affected by leishmaniasis. Histologically DSFP is composed of monomorphic, benign appearing spindle cells. These cells are organized in a storiform or rush mat pattern and align perpendicular around the vessels in central locations. [8],[9],[10],[11] A rare type of DFSP is characterized by dendritic cells that contain melanin and is known as 'pigmented DFSP' or 'Bednar tumor.' The clinical findings, localization, and microscopic properties of this variant are similar to that of the common type of DFSP.

Roughly 50% of DFSP lesions are found on the trunk. The rest are found on the proximal extremities and the head and neck region. Involvement of hands and feet is rare. [3],[5],[6],[7],[8],[9],[11] The clinical findings are related to the duration for which the tumor has been present. In the early phase, the tumor is an asymptomatic, small, indurated plaque. It may be pink, purplish-red, or similar to the surrounding normal skin in color. Later, rigid polypoid nodules appear, and as the nodules grow ulcerations develop on the surface. These lesions are typically fixed to the dermis. However, they are freely mobile on the deep tissues. Fixation to the deep structures has been seen at late stages or in case of local relapse. [3],[9] The early lesion usually appears as a solid nodule, as a soft depressed plaque, or as a rounded yellowish sclerotic disc.

Multiple finger-like projections grow within the nodules at the periphery of the tumor mass. The DFSP with its finger-like projections is frequently disseminated to beyond to the level of vision. Insufficient excisions of these projections were thought to be responsible for the high relapse rate. [5] The tumor invades laterally through the fascicles of the dermis over a period of many years, which may vary from half a year to 30 years. After this period, the tumor enters the growth phase and infiltrates the subcutaneus tissues and deep fascial structures. [3],[7] Satellite nodules coalesce to form a bulky mass, producing the typical protuberant appearance of well-developed lesions. Pain and increased sensitivity might indicate the early stages of the period of rapid growth. As the mass grows aggressively, the skin becomes stretched and thin, ulcerations may form, and there may be bleeding. In some untreated cases, dermal infarcts can be seen on the surface of bulky tumors. Reported diagnostic survey was up to 10 years. The average tumor size has been reported to be under 5 cm and, according to the literature, tumors of 10 cm or more are extremely rare.

The metastases rate is reported to be under 5% in DFSP. Metastases may occur many years after the onset of the disease and are mostly to lungs, followed by the regional lymph nodes; the visceral organs and bones are rarely affected. Generally, distant metastases is seen after recurrent local relapses. [3],[5],[6],[7],[8],[9] However, metastases to the lungs and pancreas have been reported in the absence of local recurrence. [5],[12] The most likely explanation for the occurrence of local relapse is insufficient local resection with positive boundary tissue on histopathology. Poor prognostic factors are older age, increased activity, and advanced period.

The tumor size and mobility is evaluated by physical examination. Blood tests are not useful for diagnosis. The scout x-rays reveal only a soft tissue mass without any other additional findings. MRI is useful to demonstrate deep tissue invasion, especially in the advanced stages. Nuclear study is useful for ruling out bone invasion. Though x-rays must be taken in all cases, computed tomography is not indicated if there is no bone invasion.

Histologically, DFSPs should be differentiated from fibrohistiocytic neoplasms and lesions such as malignant fibrous histiocytoma, atypical fibrosarcoma, dermatofibrosarcoma, infantile myofibromatosis, nodular fasciitis, keloid, and hypertrophic cicatrix, all of which may have similar pathologic findings. In the immunohistochemical investigations, the CD-34 marker is positive in all the cut slices. Other fibrohistiocytic lesions usually show negative results in CD-34 expression. [4],[5],[7],[8],[13],[14]

The preferred therapy of DFSP is radical (wide) surgical excision. The technique should include resection of a 3-cm margin of skin beyond the borders of the tumor and should include the fascia and even muscle tissue if necessary to attain negative intact borders histopathologically. [2],[3],[4],[5],[6],[8],[15],[16] Local relapse rate is below 10% after extensive excision. When the margin of surrounding skin was less than 3 cm margin the local relapse rate was around 50%. [3],[10] Relapses were mostly seen within the first 2 years. Extensive surgical excision of DFSP tumor is not possible on the hand, foot, or face areas and, in these locations, Mohs micrographic controlled surgical procedure is done. [3],[4],[5],[7],[8],[13]

Radiotherapy is of limited value in the treatment of DFSP. However, it might have some role to play when the resection border is positive or when extensive excision is not possible due to cosmetic or functional difficulties. [3],[5],[7],[8] Imatinib mesylate, a drug used in chronic myelogenous leukemia, has been successful in metastatic disease and/or relapses of the entity. [17]

It has been reported that some cases of DFSP relapse as late as 5 years after surgery. A major weakness of our study is that the follow-up time is only 2 years. However, literature reports do suggest that recurrences mostly occur within the first 1 or 2 years.

We performed a wide resection in our case, excising a 3-cm margin of intact tissue, which also included normal underlying muscle. Radiotherapy and chemotherapy were not used because the incision borders were negative on histopathology. Today our patient lives a normal life, without evidence of relapse or metastases. The history and clinical situation of our patient corresponds with that of patients in previous reports. In the literature, the average size of these tumors is reported as being under 5 cm. In our patient the tumor was 18 × 13 cm in size, which is exceptional; despite the large size there were no metastases.

To conclude, wide radical excision is the preferred surgical method for therapy of DFSP.

   References Top

1.Criscione VD, Weinstock MA. Descriptive epidemiology of dermatofibrosarcoma protuberans in the United States, 1973 to 2002. J Am Acad Dermatol 2007;56:968-73.  Back to cited text no. 1  [PUBMED]  [FULLTEXT]
2.Monnier D, Vidal C, Martin L, Danzon A, Pelletier F, Puzenat E, et al . Dermatofibrosarcoma protuberans: A population-based cancer registry descriptive study of 66 consecutive cases diagnosed between 1982 and 2002. J Eur Acad Dermatol Venereol 2006;20:1237-42.  Back to cited text no. 2  [PUBMED]  [FULLTEXT]
3.Laskin WB. Dermatofibrosarcoma protuberans. CA Cancer J Clin 1992;42:116-25.  Back to cited text no. 3  [PUBMED]  [FULLTEXT]
4.Korkolis DP, Liapakis IE, Vassilopoulos PP, Dermatofibrosarcoma protuberans: Clinicopathological aspect of an unusual cutaneous tumor. Anticancer Res 2007;27:1631-4.  Back to cited text no. 4    
5.Minter RM, Reith JD, Hochwald SN. Metastatic potential of dermatofibrosarcoma protuberans with fibrosarcomatous change. J Sur Oncol 2003;82:201-8.  Back to cited text no. 5    
6.Koh CK, Ko CB, Bury HP, Wyatt EH. Dermatofibrosacoma protuberans. Int J Dermatol 1995;34:256-60.  Back to cited text no. 6  [PUBMED]  
7.Sirvent N, Maire G, Pedeutour F. Genetics of dermatofibrosarcoma protuberans family of tumors: From ring chromosomes to tyrosine kinase inhibitor treatment. Genes Chromosomes Cancer 2003;37:1-19.  Back to cited text no. 7  [PUBMED]  [FULLTEXT]
8.Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS. Cancer surveillance series: Recent trends in childhood cancer incidence and mortality in the United States. J Natl Cancer Inst 1999;91:1051-8.  Back to cited text no. 8    
9.Lever WF, Schaumburg-Lever G, editors. Histopathology of the skin. 6 th ed. Philadelphia: J.B. Lippincott Company; 1983.  Back to cited text no. 9    
10.Yazdanpanah MJ, Noorbakhsh SR, Kalantari MR, Maleki M, Kiafar B. Dermatofibrosarcoma protuberans occuring in the site of prior leishmanization. Int J Dermatol 2006;45:1476.  Back to cited text no. 10    
11.Green JJ, Heymann WR. Dermatofibrosarcoma protuberans occuring in a smallpox vaccination scar. J Am Acad Dermatol 2003;48:554-5.  Back to cited text no. 11    
12.Turgut AT, Ko?ar U, Ergeneci A, Çakmak H. Lokal rekurrens bulunmaks?z?n akciger metastaz? gφsteren dermatofibrosarkom protuberans. Tan?sal ve Giri?imsel Radyoloji 2003;9:195-8.  Back to cited text no. 12    
13.Garcia C, Clark RE, Buchanan M. Dermatofibrosarcoma Protuberans. Int J Dermatol 1996;35:867-71.  Back to cited text no. 13    
14.Gu W, Ogose A, Kawashima H, Umezu H, Kudo N, Hotta T, et al . Congenital dermatofibrosarcoma protuberans with fibrosarcomatous and myxoid change. J Clin Pathol 2005;58:984-6.  Back to cited text no. 14    
15.Popov P, Bφhling T, Asko-Seljavaarra S, Tukiainen E. Microscopic margins and results of surgery for dermatofibrosarcoma protuberans. Plast Reconstr Surg 2007;119:1779.  Back to cited text no. 15    
16.Yokoyama Y, Murakami Y, Sasaki M, Morifugi M, Hayashidani N, Koboyashi T, et al . Pancraatic metastasis of dermatofibrosarcoma protuberans. J Gastroenterol 2004;39:798-800.  Back to cited text no. 16    
17.Kasper B, Lossignol D, Gil T, Flamen P, De Saint Aubain N, Awada A. Imatinib mesylate in a patient with metastatic disease originating from a dermatofibrosarcoma protuberans of the scalp. Anti Cancer Drug 2006;17:1223-5.  Back to cited text no. 17    


  [Figure 1], [Figure 2], [Figure 3], [Figure 4], [Figure 5], [Figure 6], [Figure 7], [Figure 8]


Print this article  Email this article